Empfehlungen zu SARS-CoV-2/COVID-19 in Schwangerschaft, Geburt und Wochenbett – Update November 2021 (Langfassung)

Zusammenfassung

Seit Beginn der SARS-CoV-2-Pandemie haben die Deutsche Gesellschaft für Gynäkologie und Geburtshilfe und die Gesellschaft für Peri-/Neonatalmedizin Empfehlungen zum Umgang mit SARS-CoV-2-positiven Schwangerschaften und Neugeborenen veröffentlicht und wiederholt aktualisiert. Als Weiterführung der bestehenden Empfehlungen werden in dem aktuellen Update Schlüsselfragen zur prä-, peri- und postnatalen Versorgung von Schwangeren, Gebärenden, Wöchnerinnen, Stillenden mit SARS-CoV-2 und COVID-19 sowie deren Un- oder Neugeborenen auf der Grundlage von Veröffentlichungen bis zum September 2021 behandelt. Die Empfehlungen und Stellungnahmen wurden sorgfältig aus den aktuell verfügbaren wissenschaftlichen Daten abgeleitet und anschließend im Expertenkonsens verabschiedet. Dieser Leitfaden – hier in der Langfassung vorliegend – soll eine Hilfe für die klinische Entscheidungsfindung darstellen. Die Auslegung und therapeutische Verantwortung obliegen weiterhin dem betreuenden medizinischen Team vor Ort, dessen Entscheidungen durch diese Empfehlungen unterstützt werden sollen. Aufgrund der raschen Dynamik neuer Erkenntnisse kann eine Anpassung erforderlich sein. Die Empfehlungen werden durch die Zustimmung der Fachgesellschaften getragen: Deutsche Gesellschaft für Perinatale Medizin (DGPM), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Deutsche Gesellschaft für Pränatal- und Geburtsmedizin (DGPGM), Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI), Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI).

Abstract

Since the onset of the SARS-CoV-2 pandemic, the German Society of Gynecology and Obstetrics and the Society for Peri-/Neonatal Medicine have published and repeatedly updated recommendations for the management of SARS-CoV-2 positive pregnancies and neonates. As a continuation of existing recommendations, the current update addresses key issues related to the prenatal, perinatal, and postnatal care of pregnant women, women who have given birth, women who have recently given birth, women who are breastfeeding with SARS-CoV-2 and COVID-19, and their unborn or newborn infants, based on publications through September 2021. Recommendations and opinions were carefully derived from currently available scientific data and subsequently adopted by expert consensus. This guideline – here available in the long version – is intended to be an aid to clinical decision making. Interpretation and therapeutic responsibility remain with the supervising local medical team, whose decisions should be supported by these recommendations. Adjustments may be necessary due to the rapid dynamics of new evidence. The recommendations are supported by the endorsement of the professional societies: German Society for Perinatal Medicine (DGPM), German Society of Gynecology and Obstetrics (DGGG), German Society for Prenatal and Obstetric Medicine (DGPGM), German Society for Pediatric Infectiology (DGPI), Society for Neonatology and Pediatric Intensive Care Medicine (GNPI).

Schlüsselwörter

SARS-CoV-2 - COVID-19 - Schwangerschaft - Geburt - Wochenbett - Stillen - Impfung

Key words

SARS-CoV-2 - COVID-19 - pregnancy - birth - childbed - breastfeeding - vaccinationonline publiziert 2022

Publikationsverlauf

Artikel online veröffentlicht:
16. Dezember 2021

• Literatur

• 1 Takla AM-KD, Bogdan C, Harder T, Ledig T, Neufeind J, Pecks U, Schleußner E, van der Sande M, Röbl-Mathieu M. Empfehlung und Begründung der STIKO zur Impfung gegen COVID- 19 von Schwangeren und Stillenden. Epid Bull 2021; 38: 10-36
• 2 Beig Parikhani A, Bazaz M, Bamehr H, Fereshteh S, Amiri S, Salehi-Vaziri M. et al. The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options. Curr Microbiol 2021; 78: 1099-1114
• 3 Cochrane. COVID-19 review of national clinical practice guidelines for key questions relating to the care of pregnant women and their babies: Cochrane; 2020 [International Consensus]. Available from: https://pregnancy.cochrane.org/news/covid-19-review-national- clinical-practice-guidelines-key-questions-relating-care-pregnant.
• 4 RKI. Erweiterte Hygienemaßnahmen im Gesundheitswesen im Rahmen der COVID-19 Pandemie 2020 [updated 05/13/2020. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/erweiterte_Hygiene.html
• 5 Boelig RC, Saccone G, Bellussi F, Berghella V. MFM guidance for COVID-19. Am J Obstet Gynecol MFM 2020; 100106. doi: 10.1016/j.ajogmf.2020.100106
• 6 DGGG. Empfohlene Präventionsmaßnahmen für die geburtshilfliche Versorgung in deutschen Krankenhäusern und Kliniken im Zusammenhang mit dem Coronavirus 16.03.2020. 2020 [updated 03/16/2020. Available from: https://www.dggg.de/fileadmin/documents/Weitere_Nachrichten/2020/COVID-19_DGGG- Empfehlungen_fuer_Kreissaele_20200319_f.pdf
• 7 DGPI. Umgang mit Neugeborenen SARS-CoV-2 positiver Mütter mit oder ohne klinische Erkrankung (COVID-19) 2020 [updated 03/31/2020. Available from: https://dgpi.de/stellungnahme-dgpi-dggg-dgpm-umgang-mit-neugeborenen-sars-cov-2- positiver-muetter/
• 8 RKI. COVID-19 (Coronavirus SARS-CoV-2) 2020 [updated 06222020. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/nCoV.html
• 9 Jamieson DJ, Steinberg JP, Martinello RA, Perl TM, Rasmussen SA. Obstetricians on the Coronavirus Disease 2019 (COVID-19) Front Lines and the Confusing World of Personal Protective Equipment. Obstet Gynecol 2020; 135: 1257-1263
• 10 Kagan KO, Chaoui R. Ultraschall in der Schwangerschaft wahrend der Corona-Virus Pandemie: Ein praktisches Vorgehen. Ultraschall Med 2020; 237–243
• 11 Bourne T, Leonardi M, Kyriacou C, Al-Memar M, Landolfo C, Cibula D. et al. ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2. Ultrasound Obstet Gynecol 2020; 55: 879-885
• 12 Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental Pathology in COVID-19. Am J Clin Pathol 2020; 23–32
• 13 CDC. Interim Considerations for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Inpatient Obstetric Healthcare Settings 2020
• 14 McIntosh JJ. Corticosteroid Guidance for Pregnancy during COVID-19 Pandemic. Am J Perinatol 2020; 37: 809-812
• 15 D'Souza R, Ashraf R, Rowe H, Zipursky J, Clarfield L, Maxwell C. et al. Pregnancy and COVID-19: Pharmacologic Considerations. Ultrasound Obstet Gynecol 2020; 195–203
• 16 Schleussner E. The prevention, diagnosis and treatment of premature labor. Dtsch Arztebl Int 2013; 110: 227-235 quiz 36.
• 17 Berghella V. Coronavirus disease 2019 (COVID-19): Pregnancy issues UpToDate®: UpToDate, Inc.; 2020 [updated May 27, 2020]. Literature review current through: Apr 2020: [Available from: https://www.uptodate.com/contents/coronavirus-disease-2019-covid- 19-pregnancy- issues?search=covid%2019%20pregnancy&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
• 18 D'Souza R, Malhame I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020; 99: 1110-1120
• 19 Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E. et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 75: 2950-2973
• 20 Metz TD, Clifton RG, Hughes BL, Sandoval G, Saade GR, Grobman WA. et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID- 19). Obstet Gynecol 2021; 137: 571-580
• 21 Servante J, Swallow G, Thornton JG, Myers B, Munireddy S, Malinowski AK. et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth 2021; 21: 108
• 22 D'Souza R, Malhame I, Teshler L, Acharya G, Hunt BJ, McLintock C. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19. Acta Obstet Gynecol Scand 2020; 1110–1120
• 23 Bongiovanni D, Klug M, Lazareva O, Weidlich S, Biasi M, Ursu S. et al. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell Death Dis 2021; 12: 50
• 24 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol 2021; 17: 46-64
• 25 RCOG. Coronavirus (COVID-19) Infection in Pregnancy 2020 [updated 06/04/2020. Version 10: [Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/2020-06-04-coronavirus-covid- 19-infection-in-pregnancy.pdf
• 26 Kadir RA, Kobayashi T, Iba T, Erez O, Thachil J, Kazi S. et al. COVID-19 Coagulopathy in Pregnancy: Critical Review, Preliminary Recommendations and ISTH Registry – Communication from the ISTH SSC for Women's Health. J Thromb Haemost 2020
• 27 Kaptein FHJ, Stals MAM, Huisman MV, Klok FA. Prophylaxis and treatment of COVID-19 related venous thromboembolism. Postgrad Med 2021; 133: 27-35
• 28 Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020; 18: 1023-1026
• 29 Knol HM, Schultinge L, Erwich JJ, Meijer K. Fondaparinux as an alternative anticoagulant therapy during pregnancy. J Thromb Haemost 2010; 8: 1876-1879
• 30 AWMF. S3-Leitlinie - Empfehlungen zur stationären Therapie von Patienten mit COVID- 19 AWMF-Register-Nr 113/001 2021
• 31 Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit Care Med 2020; 48: 1358-1364
• 32 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021; 46: 1-14
• 33 Donders F, Lonnee-Hoffmann R, Tsiakalos A, Mendling W, Martinez de Oliveira J, Judlin P. et al. ISIDOG Recommendations Concerning COVID-19 and Pregnancy. Diagnostics (Basel). 2020;10(4).
• 34 Stephens AJ, Barton JR, Bentum NA, Blackwell SC, Sibai BM. General Guidelines in the Management of an Obstetrical Patient on the Labor and Delivery Unit during the COVID-19 Pandemic. Am J Perinatol 2020; 829–836
• 35 Oxford-Horrey C, Savage M, Prabhu M, Abramovitz S, Griffin K, LaFond E. et al. Putting It All Together: Clinical Considerations in the Care of Critically Ill Obstetric Patients with COVID-19. Am J Perinatol 2020; 37: 1044-1051
• 36 Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S. et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet 2020
• 37 Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020
• 38 Jafari M, Pormohammad A, Sheikh Neshin SA, Ghorbani S, Bose D, Alimohammadi S. et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol 2021; 31: 1-16
• 39 Cunarro-Lopez Y, Pintado-Recarte P, Cueto-Hernandez I, Hernandez-Martin C, Paya- Martinez MP, Munoz-Chapuli MDM. et al. The Profile of the Obstetric Patients with SARS-CoV-2 Infection According to Country of Origin of the Publication: A Systematic Review of the Literature. J Clin Med 2021;10(2)
• 40 Capobianco G, Saderi L, Aliberti S, Mondoni M, Piana A, Dessole F. et al. COVID-19 in pregnant women: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020; 252: 543-558
• 41 Dubey P, Reddy SY, Manuel S, Dwivedi AK. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta- analysis. Eur J Obstet Gynecol Reprod Biol 2020; 252: 490-501
• 42 Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C. et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020; 369: m2107
• 43 Remaeus K, Savchenko J, Brismar Wendel S, Gidlof SB, Graner S, Jones E. et al. Characteristics and short-term obstetric outcomes in a case series of 67 women tested positive for SARS-CoV-2 in Stockholm, Sweden. Acta Obstet Gynecol Scand 2020
• 44 DGPM. CRONOS Registerstudie [Vorläufiger Datenstand 21.08.2021 (abschließende Auswertung ausstehend):[Available from https://www.dgpm-online.org/gesellschaft/covid- 19/cronos-registerstudie/
• 45 Ferrazzi E, Frigerio L, Savasi V, Vergani P, Prefumo F, Barresi S. et al. Vaginal delivery in SARS-CoV-2 infected pregnant women in Northern Italy: a retrospective analysis. BJOG 2020
• 46 Edward Morris POB, Goodyear G, Relph S, Jardine J, Powell A, Gilgunn-Jones E. Ed Mullins, Russell Viner, David Evans, Mary Ross-Davie. Coronavirus (COVID-19) Infection in Pregnancy - Information for healthcare professionals 2020 [updated 05/13/2020. Available from https://www.rcog.org.uk/globalassets/documents/guidelines/2020-05-13-coronavirus-covid- 19-infection-in-pregnancy.pdf
• 47 Gracia-Perez-Bonfils A, Martinez-Perez O, Llurba E, Chandraharan E. Fetal heart rate changes on the cardiotocograph trace secondary to maternal COVID-19 infection. Eur J Obstet Gynecol Reprod Biol 2020; 252: 286-293
• 48 Colon-Aponte C, Saad A, Ndubizu C, Galli J, Ahn H, Abhari P. et al. SARS-CoV-2 in pregnancy, placental fetal vascular malperfusion and the effect on fetal heart rate tracings. American Journal of Obstetrics and Gynecology 2021; 224: S374-S374
• 49 Britton GJ, Chen-Liaw A, Cossarini F, Livanos AE, Spindler MP, Plitt T. et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. medRxiv 2020
• 50 Barth RE, De Regt MJA. Persistence of viral RNA in stool samples from patients recovering from covid-19. BMJ 2020; 369: m1724
• 51 Amirian ES. Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health. Int J Infect Dis 2020; 95: 363-370
• 52 Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L. et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020; 369: m1985
• 53 Cai J, Tang M, Gao Y, Zhang H, Yang Y, Zhang D. et al. Cesarean Section or Vaginal Delivery to Prevent Possible Vertical Transmission From a Pregnant Mother Confirmed With COVID-19 to a Neonate: A Systematic Review. Front Med (Lausanne) 2021; 8: 634949
• 54 Rottenstreich A, Tsur A, Braverman N, Kabiri D, Porat S, Benenson S. et al. Vaginal delivery in SARS-CoV-2-infected pregnant women in Israel: a multicenter prospective analysis. Arch Gynecol Obstet 2021; 303: 1401-1405
• 55 Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A. et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021; 175: 817-826
• 56 Cuerva MJ, Carbonell M, Martin Palumbo G, Lopez Magallon S, De La Calle M, Bartha JL. Personal Protective Equipment during the COVID-19 pandemic and operative time in cesarean section: retrospective cohort study. J Matern Fetal Neonatal Med 2020:1–4
• 57 Sutton D, Fuchs K, D'Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. N Engl J Med 2020
• 58 Khalil A, Hill R, Ladhani S, Pattisson K, O'Brien P. SARS-CoV-2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. Am J Obstet Gynecol 2020
• 59 e.V. DGfA-uV. COVID-19 Empfehlung der DGAV e.V. 2020 [updated 04/24/2020. Available from: https://www.awmf.org/fileadmin/user_upload/Stellungnahmen/Medizinische_Versorgung/D GAV_COVID_Empfehlung2.pdf
• 60 e.V. PDGfGuG. DGGG EMPFIEHLT: VÄTER BEI DER GEBURT ZULASSEN – AUCH IN ZEITEN DER CORONA-PANDEMIE 2020 [Pressemitteilung der DGGG]. Available from: https://www.dggg.de/presse-news/pressemitteilungen/mitteilung/dggg-empfiehlt-vaeter-bei- der-geburt-zulassen-auch-in-zeiten-der-corona-pandemie-1195/
• 61 Stillkommission N. Stillen und COVID-19 – Stellungnahme der Nationalen Stillkommission vom 11. März 2020 2020 [updated 03/11/2020. Available from https://www.mri.bund.de/de/themen/nationale-stillkommission/stellungnahmen/stillen- covid-19/
• 62 Mayopoulos G, Ein-Dor T, Li K, Chan S, Dekel S. Giving birth under hospital visitor restrictions: Heightened acute stress in childbirth in COVID-19 positive women. Res Sq. 2020
• 63 Waterman RS, Brzenski A, Robbins K, Frugoni B, Reyes G, Khoche S. et al. Recommendations for developing clinical care protocols during pandemics: From theory and practice. Best Pract Res Clin Anaesthesiol 2021; 35: 461-475
• 64 Martinez Santos L, Olabarrieta Zarain U, Garcia Trancho A, Serna de la Rosa RM, Vallinas Hidalgo I, Marono Boedo MJ. et al. Anesthetic planning and management for a caesarian section in a pregnant woman affected by SARS-COV-2 pneumonia. Rev Esp Anestesiol Reanim (Engl Ed) 2021; 68: 46-49
• 65 Peter Kranke SW, Sitter M, Meybohm P, Girard T. Obstetric Anesthesia During the SARS-CoV-2 Pandemic – a Brief Overview of Published Recommendations for Action by National and International Specialist Societies and Committees. Anästhesiol Intensivmed Notfallmed Schmerzther 2020; 55: 266-274
• 66 Morau E, Bouvet L, Keita H, Vial F, Bonnet MP, Bonnin M. et al. Anaesthesia and intensive care in obstetrics during the COVID-19 pandemic. Anaesth Crit Care Pain Med 2020; 39: 345-349
• 67 Magoon R, Choudhary N, Saxena K. Labour analgesia in COVID-19 positive parturients: Points to ponder!. Trends Anaesth Crit 2021; 38: 16-17
• 68 Landau R. COVID-19 Pandemic and Obstetric Anaesthesia. Anaesth Crit Care Pain Med 2020; 39: 327-328
• 69 Bauer ME, Bernstein K, Dinges E, Delgado C, El-Sharawi N, Sultan P. et al. Obstetric Anesthesia During the COVID-19 Pandemic. Anesth Analg 2020; 131: 7-15
• 70 Mihaela Podovei KB, Ronald George, Ashraf Habib, Rachel Kacmar, Brian Bateman and Ruth Landau Interim Considerations for Obstetric Anesthesia Care related to COVID19 [PDF]. 2020 [updated 05/22/2020. Available from https://soap.org/wp- content/uploads/2020/05/SOAP_COVID-19_Obstetric_Anesthesia_Care_052220.pdf
• 71 RCOG TRCoOaG. Coronavirus (COVID-19) Infection in Pregnancy Information for healthcare professionals 2020 Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/2020-07-24-coronavirus-covid- 19-infection-in-pregnancy.pdf
• 72 WHO. Q&A: Pregnancy, childbirth and COVID-19 2020 [updated 18 March 2020. Available from https://www.who.int/emergencies/diseases/novel-coronavirus- 2019/question-and-answers-hub/q-a-detail/q-a-on-covid-19-pregnancy-and-childbirth.
• 73 Benlolo S, Nensi A, Campbell DM, Assouad C, Taylor TS, Shore EM. The Use of In Situ Simulation to Enhance COVID-19 Pandemic Preparedness in Obstetrics. Cureus 2021;13(1)
• 74 ACOG. Novel Coronavirus 2019 (COVID-19) 2020 [updated 05/19/2020. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel- coronavirus-2019
• 75 Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA. et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581: 465-469
• 76 Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR. et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020; 382: 2081-2090
• 77 RKI. SARS-CoV-2 Steckbrief zur Coronavirus-Krankheit-2019 (COVID-19). 2020
• 78 (WHO) WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected, interim guidance 27 May 2020 2020. Available from: https://www.who.int/ publications/i/item/clinical-management-of-covid-19
• 79 Gale C, Quigley MA, Placzek A, Knight M, Ladhani S, Draper ES. et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc 2021; 5: 113-121
• 80 Martenot A, Labbassi I, Delfils-Stern A, Monroy O, Langlet C. Pichault-Klein V, et al. Favorable outcomes among neonates not separated from their symptomatic SARS-CoV-2- infected mothers. Pediatric Research 2021; 90: 8-11
• 81 CDC. Care for newborns. 2020 Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html
• 82 ACOG. Summary of Key Updates (September 25,2020). 2020
• 83 Minckas N, Medvedev MM, Adejuyigbe EA, Brotherton H, Chellani H, Estifanos AS. et al. Preterm care during the COVID-19 pandemic: A comparative risk analysis of neonatal deaths averted by kangaroo mother care versus mortality due to SARS-CoV-2 infection. Eclinicalmedicine 2021;33
• 84 Wang YY, Chen L, Wu TC, Shi HF, Li Q, Jiang H. et al. Impact of Covid-19 in pregnancy on mother's psychological status and infant's neurobehavioral development: a longitudinal cohort study in China. Bmc Medicine 2020;18(1)
• 85 CDC. Coronavirus Disease 2019 (COVID-19) Evaluation and Management Considerations for Neonates At Risk for COVID-19. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html
• 86 Mand N, Iannaccone A, Longardt AC, Hutten M, Mense L, Oppelt P. et al. Neonatal outcome following maternal infection with SARS-CoV-2 in Germany: COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS). Arch Dis Child Fetal Neonatal Ed 2021
• 87 Williams J, Namazova-Baranova L, Weber M, Vural M, Mestrovic J, Carrasco-Sanz A. et al. The Importance of Continuing Breastfeeding during Coronavirus Disease-2019: In Support of the World Health Organization Statement on Breastfeeding during the Pandemic. J Pediatr 2020; 223: 234-236
• 88 Peng S, Zhu H, Yang L, Cao L, Huang X, Dynes M. et al. A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19. Lancet Reg Health West Pac 2020; 4: 100045
• 89 Bhatt H. Should COVID-19 Mother Breastfeed her Newborn Child? A Literature Review on the Safety of Breastfeeding for Pregnant Women with COVID-19. Curr Nutr Rep 2021; 10: 71-75
• 90 Haiek LN, LeDrew M, Charette C, Bartick M. Shared decision-making for infant feeding and care during the coronavirus disease 2019 pandemic. Matern Child Nutr 2021; 17: e13129
• 91 Sanchez-Luna M, Fernandez Colomer B, de Alba Romero C, Alarcon Allen A, Bana Souto A, Camba Longueira F. et al. Neonates Born to Mothers With COVID-19: Data From the Spanish Society of Neonatology Registry. Pediatrics 2021;147(2)
• 92 Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L. et al. Corrigendum to: A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage. J Infect Dis 2020 .
• 93 Gross R, Conzelmann C, Muller JA, Stenger S, Steinhart K, Kirchhoff F. et al. Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020
• 94 Martins-Filho PR, Santos VS, Santos HP. To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19. Rev Panam Salud Publica 2020; 44: e59
• 95 Chambers C, Krogstad P, Bertrand K, Contreras D, Tobin NH, Bode L. et al. Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women. JAMA 2020
• 96 Vasques da Costa A, Purcell Goes C, Gama P. Breastfeeding importance and its therapeutic potential against SARS-CoV-2. Physiol Rep 2021; 9: e14744
• 97 Dong Y, Chi X, Hai H, Sun L, Zhang M, Xie WF. et al. Antibodies in the breast milk of a maternal woman with COVID-19. Emerg Microbes Infect 2020; 9: 1467-1469
• 98 Gao X, Wang S, Zeng W, Chen S, Wu J, Lin X. et al. Clinical and immunologic features among COVID-19-affected mother-infant pairs: antibodies to SARS-CoV-2 detected in breast milk. New Microbes New Infect 2020; 37: 100752
• 99 Bertino E, Moro GE, De Renzi G, Viberti G, Cavallo R, Coscia A. et al. Detection of SARS- CoV-2 in Milk From COVID-19 Positive Mothers and Follow-Up of Their Infants. Frontiers in Pediatrics 2020; 8
• 100 Fox A, Marino J, Amanat F, Krammer F, Hahn-Holbrook J, Zolla-Pazner S. et al. Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk. Iscience 2020; 23 (11)
• 101 Demers-Mathieu V, DaPra C, Mathijssen GB, Medo E. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43. Journal of Perinatology 2021; 41: 952-960
• 102 Quitadamo PA, Comegna L, Cristalli P. Anti-Infective, Anti-Inflammatory, and Immunomodulatory Properties of Breast Milk Factors for the Protection of Infants in the Pandemic From COVID-19. Frontiers in Public Health 2021; 8
• 103 Martins-Filho PR, Tanajura DM, Santos HP, Santos VS. COVID-19 during pregnancy: Potential risk for neurodevelopmental disorders in neonates?. Eur J Obstet Gynecol Reprod Biol 2020; 250: 255-256
• 104 Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance JAMA 2020
• 105 Coronaviridae Study Group of the International Committee on Taxonomy of V The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536-544
• 106 Gerste RD. Thrombose-Pathogenese: Endotheldysfunktion bei COVID-19. Deutsches Ärzteblatt 2020; 22–23/2020: 2
• 107 Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395: 1417-1418
• 108 Pfortmueller CA, Spinetti T, Urman RD, Luedi MM, Schefold JC. COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review. Best Pract Res Clin Anaesthesiol 2021; 35: 351-368
• 109 Campbell KH, Tornatore JM, Lawrence KE, Illuzzi JL, Sussman LS, Lipkind HS. et al. Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut. JAMA. 2020
• 110 Zöllkau JBM, Scherag A, Schleußner E, Groten T. Periodenprävalenz von SARS-CoV-2 in einer unselektierten Stichprobe schwangerer Frauen in Jena – Thüringen. ZGN 2020
• 111 Pettirosso E, Giles M, Cole S, Rees M. COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission. Aust N Z J Obstet Gynaecol 2020
• 112 Stanczyk P, Jachymski T, Sieroszewski P. COVID-19 during pregnancy, delivery and postpartum period based on EBM. Ginekol Pol 2020; 91: 417-423
• 113 Selim M, Mohamed S, Abdo M, Abdelhaffez A. Is COVID-19 Similar in Pregnant and Non-Pregnant Women?. Cureus 2020; 12: e8888
• 114 Wenling Y, Junchao Q, Xiao Z, Ouyang S. Pregnancy and COVID-19: management and challenges. Rev Inst Med Trop Sao Paulo 2020; 62: e62
• 115 Thompson JL, Nguyen LM, Noble KN, Aronoff DM. COVID-19-related disease severity in pregnancy. Am J Reprod Immunol 2020; e13339. doi: 10.1111/aji.13339
• 116 Hanna N, Hanna M, Sharma S. Is pregnancy an immunological contributor to severe or controlled COVID-19 disease? Am J Reprod Immunol 2020; e13317. doi: 10.1111/aji.13317
• 117 Molteni E, Astley CM, Ma W, Sudre CH, Magee LA, Murray B. et al. SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology. medRxiv 2020
• 118 Lokken EM, Taylor GG, Huebner EM, Vanderhoeven J, Hendrickson S, Coler B. et al. Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients. Am J Obstet Gynecol 2021; 225: 75 e1-e16
• 119 Gurol-Urganci I, Jardine JE, Carroll F, Draycott T, Dunn G, Fremeaux A. et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol 2021
• 120 Di Mascio D, Sen C, Saccone G, Galindo A, Grunebaum A, Yoshimatsu J. et al. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19. J Perinat Med. 2020; 950-958
• 121 Sahu AK, Sreepadmanabh M, Rai M, Chande A. SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology. Virusdisease; 2021:1–12
• 122 Vousden N, Bunch K, Morris E, Simpson N, Gale C, O'Brien P. et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One 2021; 16: e0251123
• 123 Badr DA, Picone O, Bevilacqua E, Carlin A, Meli F, Sibiude J. et al. Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection. Emerg Infect Dis 2021; 27: 2535-2543
• 124 Blitz MJ, Rochelson B, Prasannan L, Shan W, Chervenak FA, Nimaroff M. et al. Race/ethnicity and spatiotemporal trends in SARS-CoV-2 prevalence on obstetrical units in New York. Am J Obstet Gynecol MFM; 2020:100212. doi: 10.1016/j.ajogmf.2020.100212
• 125 Emeruwa UN, Spiegelman J, Ona S, Kahe K, Miller RS, Fuchs KM. et al. Influence of Race and Ethnicity on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Rates and Clinical Outcomes in Pregnancy. Obstet Gynecol 2020
• 126 Flannery DD, Gouma S, Dhudasia MB, Mukhopadhyay S, Pfeifer MR, Woodford EC. et al. SARS-CoV-2 seroprevalence among parturient women in Philadelphia. Sci Immunol 2020; 5 (49)
• 127 Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD. et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 769-775
• 128 Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT. et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1641-1647
• 129 Moore JT, Ricaldi JN, Rose CE, Fuld J, Parise M, Kang GJ. et al. Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5-18, 2020 - 22 States, February-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1122-1126
• 130 Pineles BL, Alamo IC, Farooq N, Green J, Blackwell SC, Sibai BM. et al. Racial-ethnic disparities and pregnancy outcomes in SARS-CoV-2 infection in a universally-tested cohort in Houston, Texas. Eur J Obstet Gynecol Reprod Biol 2020
• 131 Prasannan L, Rochelson B, Shan W, Nicholson K, Solmonovich R, Kulkarni A. et al. Social determinants of health and coronavirus disease 2019 in pregnancy. Am J Obstet Gynecol MFM 2021; 3: 100349
• 132 Haizler-Cohen L, Moncada K, Collins A, Davidov A, Fruhman G. 611 Racial, ethnic and socioeconomic disparities in susceptibility to SARS-CoV-2 in pregnancy. American Journal of Obstetrics and Gynecology 2021; 224: S383-S384
• 133 Metz TD, Collier C, Hollier LM. Maternal Mortality From Coronavirus Disease 2019 (COVID-19) in the United States. Obstet Gynecol 2020; 136: 313-316
• 134 Kayem G, Lecarpentier E, Deruelle P, Bretelle F, Azria E, Blanc J. et al. A snapshot of the Covid-19 pandemic among pregnant women in France. J Gynecol Obstet Hum Reprod 2020; 49: 101826
• 135 Kucirka LM, Norton A, Sheffield J. Severity of COVID-19 In Pregnancy: A Review of Current Evidence. Am J Reprod Immunol 2020: e13332
• 136 Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K. et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020: 100118
• 137 Gao YJ, Ye L, Zhang JS, Yin YX, Liu M, Yu HB. et al. Clinical features and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2020; 20: 564
• 138 Antoun L, Taweel NE, Ahmed I, Patni S, Honest H. Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: A prospective cohort study. Eur J Obstet Gynecol Reprod Biol 2020; 252: 559-562
• 139 Collin J, Byström E, Carnahan A, Ahrne M. Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstetricia et Gynecologica Scandinavica 2020; 99: 819-822
• 140 Delahoy MJ, Whitaker M, O'Halloran A, Chai SJ, Kirley PD, Alden N. et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory- Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1347-1354
• 141 Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kharbanda EO, Ryan DS. et al. SARS- CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1355-1359
• 142 Oakes MC, Kernberg AS, Carter EB, Foeller ME, Palanisamy A, Raghuraman N. et al. Pregnancy as a risk factor for severe coronavirus disease 2019 using standardized clinical criteria. Am J Obstet Gynecol MFM 2021; 3: 100319
• 143 Reis H, Boldrini NAT, Caldas JVJ, Paz A, Ferrugini CLP, Miranda AE. Severe coronavirus infection in pregnancy: challenging cases report. Rev Inst Med Trop Sao Paulo 2020; 62: e49
• 144 Barbero P, Muguerza L, Herraiz I, Garcia Burguillo A, San Juan R, Forcen L. et al. SARS- CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19. J Matern Fetal Neonatal Med 2020: 1–7. doi: 10.1080/14767058.2020.1793320
• 145 San-Juan R, Barbero P, Fernandez-Ruiz M, Lopez-Medrano F, Lizasoain M, Hernandez- Jimenez P. et al. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. EClinicalMedicine 2020; 23: 100407
• 146 ICNARC ICNARC. Report on COVID-19 in critical care: England,Wales and Northern Ireland. 2021 [updated 15.01.2021]. Available from https://www.icnarc.org/Our- Audit/Audits/Cmp/Reports
• 147 Polcer RE, Jones E, Pettersson K. A Case Series on Critically Ill Pregnant or Newly Delivered Patients with Covid-19, Treated at Karolinska University Hospital, Stockholm. Case Rep Obstet Gynecol 2021; 2021: 8868822
• 148 Lokken EM, Huebner EM, Taylor GG, Hendrickson S, Vanderhoeven J, Kachikis A. et al. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol 2021; 225: 77 e1-e14
• 149 Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T. et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370: m3320
• 150 Khoury R, Bernstein PS, Debolt C, Stone J, Sutton DM, Simpson LL. et al. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers. Obstet Gynecol 2020; 136: 273-282
• 151 Cohen J, Vignaux O, Jacquemard F. Covid-19 in pregnant women: General data from a French National Survey. Eur J Obstet Gynecol Reprod Biol 2020; 251: 267-268
• 152 Martinez-Portilla RJ, Smith ER, He S, Torres-Torres J, Espino YSS, Solis-Paredes JM. et al. Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: analysis of the Mexican National Surveillance Program. Am J Obstet Gynecol 2021; 224: 404-407
• 153 La Verde M, Riemma G, Torella M, Cianci S, Savoia F, Licciardi F. et al. Maternal death related to COVID-19: A systematic review and meta-analysis focused on maternal co- morbidities and clinical characteristics. Int J Gynaecol Obstet 2021; 154: 212-219
• 154 Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021; 193: E540-E548
• 155 Driggin E, Maddox TM, Ferdinand KC, Kirkpatrick JN, Ky B, Morris AA. et al. ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2021; 77: 1938-1948
• 156 Govender R, Moodley J, Naicker T. The COVID-19 Pandemic: an Appraisal of its Impact on Human Immunodeficiency Virus Infection and Pre-Eclampsia. Curr Hypertens Rep 2021; 23: 9
• 157 Gleeson S, Noori M, Lightstone L, Webster P. Lesson for the clinical nephrologist: Kidney transplant, COVID-19 and pregnancy. J Nephrol 2021; 34: 369-371
• 158 Khalil A, Kalafat E, Benlioglu C, O'Brien P, Morris E, Draycott T. et al. SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. EClinicalMedicine 2020; 25: 100446
• 159 Di Mascio D, COVID Wwgo. Maternal and Perinatal Outcomes of Pregnant Women with SARS-COV-2 infection. Ultrasound Obstet Gynecol 2020
• 160 Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS- CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res 2020; 25: 39
• 161 Prochaska E, Jang M, Burd I. COVID-19 in pregnancy: Placental and neonatal involvement. Am J Reprod Immunol 2020: e13306
• 162 Oncel MY, Akin IM, Kanburoglu MK, Tayman C, Coskun S, Narter F. et al. A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society. Eur J Pediatr 2020
• 163 Pirkle CM. Evidence based care for pregnant women with covid-19. BMJ 2020; 370: m3510
• 164 Martinez-Portilla RJ, Sotiriadis A, Chatzakis C, Torres-Torres J, Espino YSS, Sandoval- Mandujano K. et al. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx). Ultrasound Obstet Gynecol 2021; 57: 224-231
• 165 DeBolt CA, Bianco A, Limaye MA, Silverstein J, Penfield CA, Roman AS. et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol 2021; 224: 510 e1-e12
• 166 Badr DA, Mattern J, Carlin A, Cordier AG, Maillart E, El Hachem L. et al. Are clinical outcomes worse for pregnant women at>/=20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol 2020; 223: 764-768
• 167 Pastick KA, Nicol MR, Smyth E, Zash R, Boulware DR, Rajasingham R. et al. A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials. Open Forum Infect Dis 2020; 7: ofaa350
• 168 Jering KS, Claggett BL, Cunningham JW, Rosenthal N, Vardeny O, Greene MF. et al. Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med 2021; 181: 714-717
• 169 Mullins E, Hudak ML, Banerjee J, Getzlaff T, Townson J, Barnette K. et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol 2021; 57: 573-581
• 170 Hessami K, Homayoon N, Hashemi A, Vafaei H, Kasraeian M, Asadi N. COVID-19 and maternal, fetal and neonatal mortality: a systematic review. J Matern Fetal Neonatal Med 2020: 1–6
• 171 Takemoto M, Menezes MO, Andreucci CB, Knobel R, Sousa L, Katz L. et al. Clinical characteristics and risk factors for mortality in obstetric patients with severe COVID-19 in Brazil: a surveillance database analysis. BJOG 2020; 127: 1618-1626
• 172 Qeadan F, Mensah NA, Tingey B, Stanford JB. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC Pregnancy Childbirth 2021; 21: 305
• 173 Statistisches Bundesamt über de.statista.com. Durchschnittliche Müttersterblichkeit in West- und Ostdeutschland in den Jahren von 1980 bis 2016 2019 Available from: https://de.statista.com/statistik/daten/studie/285595/umfrage/muettersterblichkeit-in- deutschland/#statisticContainer
• 174 Adhikari EH, SoRelle JA, McIntire DD, Spong CY. Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge. Am J Obstet Gynecol 2021
• 175 Vousden N, Ramakrishnan R, Bunch K, Morris E, Simpson N, Gale C. et al. Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort. medRxiv. 2021:2021.07.22.21261000
• 176 Li W, Yu N, Kang Q, Zeng W, Deng D, Chen S. et al. Clinical manifestations and maternal and perinatal outcomes with COVID-19. Am J Reprod Immunol 2020: e13340
• 177 Galang RR, Chang K, Strid P, Snead MC, Woodworth KR, House LD. et al. Severe Coronavirus Infections in Pregnancy: A Systematic Review. Obstet Gynecol 2020; 136: 262-272
• 178 Molteni E, Astley CM, Ma W, Sudre CH, Magee LA, Murray B. et al. Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts. Sci Rep 2021; 11: 6928
• 179 Longardt AC, Winkler VP, Pecks U. SARS-CoV-2 and Perinatal Aspects. Z Geburtshilfe Neonatol 2020; 224: 181-186
• 180 Massarotti C, Adriano M, Cagnacci A, Gorlero F, Gustavino C, Vallerino G. et al. Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during the complete lockdown. J Med Virol 2020
• 181 Tanacan A, Erol SA, Turgay B, Anuk AT, Secen EI, Yegin GF. et al. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey. Eur J Obstet Gynecol Reprod Biol 2020; 253: 31-34
• 182 Herraiz I, Folgueira D, Villalain C, Forcen L, Delgado R, Galindo A. Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid. J Perinat Med 2020
• 183 Miller ES, Grobman WA, Sakowicz A, Rosati J, Peaceman AM. Clinical Implications of Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Pregnancy. Obstet Gynecol 2020; 136: 232-234
• 184 Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, Kubiak JM. et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG 2020
• 185 Reale SC, Lumbreras-Marquez MI, King CH, Burns SL, Fields KG, Diouf K. et al. Patient characteristics associated with SARS-CoV-2 infection in parturients admitted for labour and delivery in Massachusetts during the spring 2020 surge: A prospective cohort study. Paediatr Perinat Epidemiol 2021; 35: 24-33
• 186 Trippella G, Ciarcia M, Ferrari M, Buzzatti C, Maccora I, Azzari C. et al. COVID-19 in Pregnant Women and Neonates: A Systematic Review of the Literature with Quality Assessment of the Studies. Pathogens. 2020; 9 (6)
• 187 Crovetto F, Crispi F, Llurba E, Figueras F, Gomez-Roig MD, Gratacos E. Seroprevalence and presentation of SARS-CoV-2 in pregnancy. Lancet. 2020; 396: 530-531
• 188 Marin Gabriel MA, Reyne Vergeli M, Caserio Carbonero S, Sole L, Carrizosa Molina T, Rivero, Calle I et al. Maternal, Perinatal and Neonatal Outcomes With COVID-19: A Multicenter Study of 242 Pregnancies and Their 248 Infant Newborns During Their First Month of Life. Pediatr Infect Dis J 2020
• 189 Afshar Y, Gaw SL, Flaherman VJ, Chambers BD, Krakow D, Berghella V. et al. Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People. Obstet Gynecol 2020; 136: 1117-1125
• 190 Gupta S, Kaushik A, Kest H, Charles AK, De Bruin W, Colletti M. et al. Severe Enteritis as the Sole Manifestation of Novel Coronavirus Disease 2019 (COVID-19) in Adolescent Patients. Case Rep Infect Dis 2020; 2020: 8823622
• 191 Schwartz RA, Lambert WC. COVID-19-specific skin changes related to SARS-CoV-2: Visualizing a monumental public health challenge. Clin Dermatol 2021; 39: 374-379
• 192 Rodriguez-Cerdeira C, Uribe-Camacho BI, Silverio-Carrasco L, Mendez W, Mahesh AR, Tejada A. et al. Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries. Biology (Basel). 2021;10(1)
• 193 Shahidi Dadras M, Diab R, Ahadi M, Abdollahimajd F. Generalized pustular psoriasis following COVID-19. Dermatol Ther 2021; 34: e14595
• 194 Cruz-Lemini M, Ferriols Perez E, de la Cruz Conty ML, Cano Aguilar A, Encinas Pardilla MB, Prats Rodriguez P. et al. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women. Viruses 2021; 13 (1)
• 195 Yang H, Sun G, Tang F, Peng M, Gao Y, Peng J. et al. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infect 2020
• 196 Yan J, Guo J, Fan C, Juan J, Yu X, Li J. et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol 2020; 223: 111 e1-e14
• 197 Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol 2020; 56: 15-27
• 198 Cosma S, Carosso AR, Cusato J, Borella F, Carosso M, Bovetti M. et al. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. Am J Obstet Gynecol 2021; 224: 391 e1-e7
• 199 la Cour Freiesleben N, Egerup P, Hviid KVR, Severinsen ER, Kolte AM, Westergaard D. et al. SARS-CoV-2 in first trimester pregnancy: a cohort study. Hum Reprod 2021; 36: 40-47
• 200 Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T. et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET- NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1635-1640
• 201 Varma P, Lybrand ZR, Antopia MC, Hsieh J. Novel Targets of SARS-CoV-2 Spike Protein in Human Fetal Brain Development Suggest Early Pregnancy Vulnerability. Front Neurosci 2020; 14: 614680
• 202 Celik T, Simsek A, Koca CF, Aydin S, Yasar S. Evaluation of cochlear functions in infants exposed to SARS-CoV-2 intrauterine. Am J Otolaryngol 2021; 42: 102982
• 203 Mullins E, Evans D, Viner RM, O'Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 2020; 55: 586-592
• 204 Kirtsman M, Diambomba Y, Poutanen SM, Malinowski AK, Vlachodimitropoulou E, Parks WT. et al. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. CMAJ. 2020; 192: E647-E650
• 205 Mulvey JJ, Magro CM, Ma LX, Nuovo GJ, Baergen RN. WITHDRAWN: A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients. Ann Diagn Pathol 2020; 46: 151529
• 206 Smithgall MC, Liu-Jarin X, Hamele-Bena D, Cimic A, Mourad M, Debelenko L. et al. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology 2020
• 207 Sharps MC, Hayes DJL, Lee S, Zou Z, Brady CA, Almoghrabi Y. et al. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection. Placenta 2020; 101: 13-29
• 208 Gao L, Ren J, Xu L, Ke X, Xiong L, Tian X. et al. Placental pathology of the third trimester pregnant women from COVID-19. Diagn Pathol 2021; 16: 8
• 209 Linehan L, O'Donoghue K, Dineen S, White J, Higgins JR, Fitzgerald B. SARS-CoV-2 placentitis: An uncommon complication of maternal COVID-19. Placenta 2021; 104: 261-266
• 210 Flores-Pliego A, Miranda J, Vega-Torreblanca S, Valdespino-Vazquez Y, Helguera- Repetto C, Espejel-Nunez A. et al. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19 Cells. 2021;10(2)
• 211 Jaiswal N, Puri M, Agarwal K, Singh S, Yadav R, Tiwary N. et al. COVID-19 as an independent risk factor for subclinical placental dysfunction.. Eur J Obstet Gynecol Reprod Biol 2021; 259: 7-11
• 212 Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, Milano KM. et al. SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface. medRxiv 2021
• 213 Gulersen M, Prasannan L, Tam HT, Metz CN, Rochelson B, Meirowitz N. et al. Histopathological evaluation of placentas after diagnosis of maternal SARS-CoV-2 infection. Am J Obstet Gynecol MFM 2020: 100211
• 214 Schoenmakers S, Snijder P, Verdijk RM, Kuiken T, Kamphuis SSM, Koopman LP. et al. Severe Acute Respiratory Syndrome Coronavirus 2 Placental Infection and Inflammation Leading to Fetal Distress and Neonatal Multi-Organ Failure in an Asymptomatic Woman. J Pediatric Infect Dis Soc 2021; 10: 556-561
• 215 Schwartz DA, Morotti D. Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2. Viruses 2020; 12(11)
• 216 Ahlberg M, Neovius M, Saltvedt S, Soderling J, Pettersson K, Brandkvist C. et al. Association of SARS-CoV-2 Test Status and Pregnancy Outcomes. JAMA 2020
• 217 Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, Garcia-May PK, Mhatre M. et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol 2021; 225: 289 e1-e17
• 218 Zelop CM, Bonney EA. COVID-19 in pregnancy: possible mechanisms not to be discounted. J Matern Fetal Neonatal Med 2020: 1–4
• 219 Abbas AM, Ahmed OA, Shaltout AS. COVID-19 and maternal pre-eclampsia: A synopsis. Scand J Immunol 2020; 92: e12918
• 220 Todros T, Masturzo B, De Francia S. COVID-19 infection: ACE2, pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2020; 253: 330
• 221 Madden N, Emeruwa U, Polin M, Bejerano S, Gyamfi-Bannerman C, Booker WA. 32 COVID-19 and new hypertensive disease in pregnancy. American Journal of Obstetrics and Gynecology 2021; 224: S23-S24
• 222 Rosenbloom JI, Raghuraman N, Carter EB, Kelly JC. Coronavirus disease 2019 infection and hypertensive disorders of pregnancy. Am J Obstet Gynecol 2021; 224: 623-624
• 223 Ville S, Le Bot S, Chapelet-Debout A, Blancho G, Fremeaux-Bacchi V, Deltombe C. et al. Atypical HUS relapse triggered by COVID-19. Kidney Int 2021; 99: 267-268
• 224 Rolnik DL. Can COVID-19 in pregnancy cause pre-eclampsia?. BJOG 2020; 127: 1381
• 225 Mendoza M, Garcia-Ruiz I, Maiz N, Rodo C, Garcia-Manau P, Serrano B. et al. Pre- eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG 2020; 127: 1374-1380
• 226 Turpin CA, Sakyi SA, Owiredu WK, Ephraim RK, Anto EO. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. BMC Pregnancy Childbirth 2015; 15: 189
• 227 Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020
• 228 Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A. et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020
• 229 Stumpfe FM, Titzmann A, Schneider MO, Stelzl P, Kehl S, Fasching PA. et al. SARS-CoV-2 Infection in Pregnancy - a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome. Geburtshilfe Frauenheilkd 2020; 80: 380-390
• 230 Martinez-Perez O, Prats Rodriguez P, Muner Hernandez M, Encinas Pardilla MB, Perez Perez N, Vila Hernandez MR. et al. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis. BMC Pregnancy Childbirth 2021; 21: 273
• 231 Rodrigues ML, Gasparinho G, Sepulveda F, Matos T. Signs suggestive of congenital SARS-CoV-2 infection with intrauterine fetal death: A case report. Eur J Obstet Gynecol Reprod Biol. 2021; 256: 508-509
• 232 Khalil A, von Dadelszen P, Draycott T, Ugwumadu A, O'Brien P, Magee L. Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic. JAMA 2020
• 233 Saccone G, Zullo F, Di Mascio D. Coronavirus disease 2019 vaccine in pregnant women: not so far! The importance of counseling and the need for evidence-based data. Am J Obstet Gynecol MFM 2021; 3: 100324
• 234 Huntley BJF, Mulder IA, Di Mascio D, Vintzileos WS, Vintzileos AM. Berghella V, et al. Adverse Pregnancy Outcomes Among Individuals With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review and Meta-analysis. Obstet Gynecol 2021; 137: 585-596
• 235 Thayer ZM, Gildner TE. COVID-19-related financial stress associated with higher likelihood of depression among pregnant women living in the United States. Am J Hum Biol 2020: e23508
• 236 Zhou Y, Shi H, Liu Z, Peng S, Wang R, Qi L. et al. The prevalence of psychiatric symptoms of pregnant and non-pregnant women during the COVID-19 epidemic. Transl Psychiatry 2020; 10: 319
• 237 Ayaz R, Hocaoglu M, Gunay T, Yardimci OD, Turgut A, Karateke A. Anxiety and depression symptoms in the same pregnant women before and during the COVID-19 pandemic. J Perinat Med 2020
• 238 Farrell T, Reagu S, Mohan S, Elmidany R, Qaddoura F, Ahmed EE. et al. The impact of the COVID-19 pandemic on the perinatal mental health of women. J Perinat Med 2020
• 239 Perzow SED, Hennessey EP, Hoffman MC, Grote NK, Davis EP, Hankin BL. Mental health of pregnant and postpartum women in response to the COVID-19 pandemic. J Affect Disord Rep 2021; 4: 100123
• 240 Jiang H, Jin L, Qian X, Xiong X, La X, Chen W. et al. Maternal Mental Health Status and Approaches for Accessing Antenatal Care Information During the COVID-19 Epidemic in China: Cross-Sectional Study. J Med Internet Res 2021; 23: e18722
• 241 Li C, Huo L, Wang R, Qi L, Wang W, Zhou X. et al. The prevalence and risk factors of depression in prenatal and postnatal women in China with the outbreak of Corona Virus Disease 2019. J Affect Disord 2021; 282: 1203-1209
• 242 Zhou Y, Wang R, Liu L, Ding T, Huo L, Qi L. et al. The impact of lockdown policy on depressive symptoms among pregnant women in China: mediating effects of internet use and family support. Glob Health Res Policy 2021; 6: 11
• 243 Goyal D, Selix NW. Impact of COVID-19 on Maternal Mental Health. MCN Am J Matern Child Nurs 2021; 46: 103-109
• 244 Osborne LM, Kimmel MC, Surkan PJ. The Crisis of Perinatal Mental Health in the Age of Covid-19. Matern Child Health J 2021; 25: 349-352
• 245 Quistorff JL, Saeed H, Lopez C, Andescavage NN, Limperopoulos C. 938 Pregnancy and COVID-19: the impact on maternal mental health. American Journal of Obstetrics and Gynecology 2021; 224: S582-S583
• 246 Akgor U, Fadiloglu E, Soyak B, Unal C, Cagan M, Temiz BE. et al. Anxiety, depression and concerns of pregnant women during the COVID-19 pandemic. Arch Gynecol Obstet 2021; 304: 125-130
• 247 Keenan-Devlin LS, Romero J, Smart BP, Docheva N, Borders A. 863 COVID-19-related perinatal stress associated with increased depression risk. American Journal of Obstetrics and Gynecology. 2021; 224: S536-S537
• 248 Kotlar B, Gerson E, Petrillo S, Langer A, Tiemeier H. The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review. Reprod Health 2021; 18: 10
• 249 Naghizadeh S, Mirghafourvand M, Mohammadirad R. Domestic violence and its relationship with quality of life in pregnant women during the outbreak of COVID-19 disease. BMC Pregnancy Childbirth 2021; 21: 88
• 250 Hamzehgardeshi Z, Omidvar S, Amoli AA, Firouzbakht M. Pregnancy-related anxiety and its associated factors during COVID-19 pandemic in Iranian pregnant women: a web- based cross-sectional study. BMC Pregnancy Childbirth 2021; 21: 208
• 251 Fan S, Guan J, Cao L, Wang M, Zhao H, Chen L. et al. Psychological effects caused by COVID-19 pandemic on pregnant women: A systematic review with meta-analysis. Asian J Psychiatr 2021; 56: 102533
• 252 Saadati N, Afshari P, Boostani H, Beheshtinasab M, Abedi P, Maraghi E. Health anxiety and related factors among pregnant women during the COVID-19 pandemic: a cross-sectional study from Iran. BMC Psychiatry 2021; 21: 95
• 253 Lopez-Morales H, Del Valle MV, Canet-Juric L, Andres ML, Galli JI, Poo F. et al. Mental health of pregnant women during the COVID-19 pandemic: A longitudinal study. Psychiatry Res 2021; 295: 113567
• 254 Fumagalli S, Ornaghi S, Borrelli S, Vergani P, Nespoli A. The experiences of childbearing women who tested positive to COVID-19 during the pandemic in northern Italy. Women Birth. 2021
• 255 Liang P, Wang Y, Shi S, Liu Y, Xiong R. Prevalence and factors associated with postpartum depression during the COVID-19 pandemic among women in Guangzhou, China: a cross-sectional study. BMC Psychiatry 2020; 20: 557
• 256 An R, Chen X, Wu Y, Liu J, Deng C, Liu Y. et al. A survey of postpartum depression and health care needs among Chinese postpartum women during the pandemic of COVID-19. Arch Psychiatr Nurs 2021; 35: 172-177
• 257 Jelly P, Chadha L, Kaur N, Sharma S, Sharma R, Stephen S. et al. Impact of COVID-19 Pandemic on the Psychological Status of Pregnant Women. Cureus. 2021; 13: e12875
• 258 Dell'Utri C, Manzoni E, Cipriani S, Spizzico C, Dell'Acqua A, Barbara G. et al. Effects of SARS Cov-2 epidemic on the obstetrical and gynecological emergency service accesses. What happened and what shall we expect now?. Eur J Obstet Gynecol Reprod Biol 2020; 254: 64-68
• 259 Meyer R, Levin G, Hendin N, Katorza E. Impact of the COVID-19 Outbreak on Routine Obstetrical Management. Isr Med Assoc J 2020; 8: 417-422
• 260 Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol 2020; 39: 2529-2543
• 261 Turan O, Hakim A, Dashraath P, Jeslyn WJL, Wright A, Abdul-Kadir R. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review. Int J Gynaecol Obstet. 2020
• 262 Wichmann D. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann Intern Med 2020; 173: 1030
• 263 Langer F, Kluge S, Klamroth R, Oldenburg J. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis. Hamostaseologie 2020; 40: 264-269
• 264 Abdel-Razeq S, Alien A, Lundsberg L, Culhane JF. 763 Hemostasis changes among COVID-19 gravidas during SARS-CoV-2 pandemic on rotational thromboelastography. American Journal of Obstetrics and Gynecology 2021; 224: S477-S477
• 265 Chan JL, Gregory KD, Smithson SS, Naqvi M, Mamelak AN. Pituitary apoplexy associated with acute COVID-19 infection and pregnancy. Pituitary 2020
• 266 Tutiya CT, Siaulys MM, Kondo MM, Miglioli-Galvao L, CAG E, Pinheiro CC. et al. Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: Two case reports. Case Rep Womens Health 2020; 27: e00237
• 267 Kinsey KE, Ganz E, Khalil S, Brustman L. Intraoperative coagulopathy during cesarean section as an unsuspected initial presentation of COVID-19: a case report. BMC Pregnancy Childbirth 2020; 20: 481
• 268 Ostovan VR, Foroughi R, Rostami M, Almasi-Dooghaee M, Esmaili M, Bidaki AA. et al. Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review. J Neurol 2021; 268: 3549-3560
• 269 LaRoy M, McGuire M. Pituitary apoplexy in the setting of COVID-19 infection. Am J Emerg Med 2021; 47: e1-e2
• 270 Robert-Koch-Institut FCa. Medikamentöse Therapie bei COVID-19 mit Bewertung durch die Fachgruppe COVRIIN am Robert-Koch-Institut. 2021:11
• 271 Devis P, Knuttinen MG. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovasc Diagn Ther 2017; 7: S309-S319
• 272 Roberts LN, Whyte MB, Georgiou L, Giron G, Czuprynska J, Rea C. et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020; 136: 1347-1350
• 273 Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC. et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020; 136: 1342-1346
• 274 RCOG. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. [Available from https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf
• 275 Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets. 2020; 31: 740-745
• 276 Bivia-Roig G, La Rosa VL, Gomez-Tebar M, Serrano-Raya L, Amer-Cuenca JJ, Caruso S. et al. Analysis of the Impact of the Confinement Resulting from COVID-19 on the Lifestyle and Psychological Wellbeing of Spanish Pregnant Women: An Internet-Based Cross-Sectional Survey. Int J Environ Res Public Health. 2020;17(16)
• 277 COV-PREG-COAG. International Registry on Pregnancy and COVID-19 Associated Coagulopathy [Available from: https://www.isth.org/page/IntlRegistry_Covid-19_Preg_Coag
• 278 Vlachodimitropoulou Koumoutsea E, Vivanti AJ, Shehata N, Benachi A, Le Gouez A, Desconclois C. et al. COVID-19 and acute coagulopathy in pregnancy. J Thromb Haemost 2020; 18: 1648-1652
• 279 Blumberg DA, Underwood MA, Hedriana HL, Lakshminrusimha S. Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?. Am J Perinatol 2020; 37: 769-772
• 280 Hou H, Wang T, Zhang B, Luo Y, Mao L, Wang F. et al. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clin Transl Immunology 2020; 9: e01136
• 281 Thomas P, Alexander PE, Ahmed U, Elderhorst E, El-Khechen H, Mammen MJ. et al. Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review. J Matern Fetal Neonatal Med. 2020:1-8
• 282 Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J. et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020; 11: 3572
• 283 Elkafrawi D, Joseph J, Schiattarella A, Rodriguez B, Sisti G. Intrauterine transmission of COVID-19 in Pregnancy: case report and review of literature. Acta Biomed 2020; 91: e2020041
• 284 Facchetti F, Bugatti M, Drera E, Tripodo C, Sartori E, Cancila V. et al. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta. EBioMedicine. 2020; 59: 102951
• 285 Stonoga ETS, de Almeida Lanzoni L, Rebutini PZ, Permegiani de Oliveira AL, Chiste JA, Fugaca CA. et al. Intrauterine Transmission of SARS-CoV-2. Emerg Infect Dis 2021; 27: 638-41.
• 286 Shende P, Gaikwad P, Gandhewar M, Ukey P, Bhide A, Patel V. et al. Persistence of SARS-CoV-2 in the first trimester placenta leading to transplacental transmission and fetal demise from an asymptomatic mother. Hum Reprod 2021; 36: 899-906
• 287 Bahadur G, Bhat M, Acharya S, Janga D, Cambell B, Huirne J. et al. Retrospective observational RT-PCR analyses on 688 babies born to 843 SARS-CoV-2 positive mothers, placental analyses and diagnostic analyses limitations suggest vertical transmission is possible. Facts Views Vis Obgyn 2021; 13: 53-66
• 288 Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID- 19 during Pregnancy and Possible Vertical Transmission. Am J Perinatol 2020; 37: 861-865
• 289 Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J. et al. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA Pediatr 2020; 174: 722-725
• 290 Sagheb S, Lamsehchi A, Jafary M, Atef-Yekta R, Sadeghi K. Two seriously ill neonates born to mothers with COVID-19 pneumonia- a case report. Ital J Pediatr 2020; 46: 137
• 291 Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O. et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020
• 292 Gale C, Quigley MA, Placzek A, Knight M, Ladhani S, Draper ES. et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance. Lancet Child Adolesc Health 2021; 5: 113-121
• 293 Patil UP, Krishnan P, Abudinen-Vasquez S, Maru S, Noble L. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positive Newborns of COVID-19 Mothers After Dyad- Care: A Case Series. Cureus. 2021; 13: e12528
• 294 Barcelos I, Penna IAA, Soligo AG, Costa ZB, Martins WP. Vertical Transmission of SARS- CoV-2: A Systematic Review. Rev Bras Ginecol Obstet 2021; 43: 207-215
• 295 Wang N, Qin L, Ma L, Yan H. Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system. Stem Cell Res 2021; 52: 102189
• 296 Llorca J, Lechosa-Muniz C, Gortazar P, Fernandez-Ortiz M, Jubete Y, Cabero MJ. et al. COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study. BMJ Open 2021; 11: e044224
• 297 Askary E, Poordast T, Shiravani Z, Ali MA, Hashemi A, Naseri R. et al. Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series. Int J Reprod Biomed 2021; 19: 191-204
• 298 Moore KM, Suthar MS. Comprehensive analysis of COVID-19 during pregnancy. Biochem Biophys Res Commun 2021; 538: 180-186
• 299 Halici-Ozturk F, Ocal FD, Aydin S, Tanacan A, Ayhan SG, Altinboga O. et al. Investigating the risk of maternal-fetal transmission of SARS-CoV-2 in early pregnancy. Placenta. 2021; 106: 25-29
• 300 Sukhikh G, Petrova U, Prikhodko A, Starodubtseva N, Chingin K, Chen H. et al. Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology. Viruses. 2021;13(3)
• 301 Yuan J, Qian H, Cao S, Dong B, Yan X, Luo S. et al. Is there possibility of vertical transmission of COVID-19: a systematic review. Transl Pediatr 2021; 10: 423-434
• 302 Mongula JE, Frenken MWE, van Lijnschoten G, Arents NLA, de Wit-Zuurendonk LD, Schimmel-de Kok APA et al. COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Ultrasound Obstet Gynecol. 2020
• 303 Mongula JE, Frenken MWE, van Lijnschoten G, Arents NLA, de Wit-Zuurendonk LD, Schimmel-de Kok APA. et al. COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Ultrasound Obstet Gynecol. 2020
• 304 Dong L, Tian J, He S, Zhu C, Wang J, Liu C. et al. Possible Vertical Transmission of SARS- CoV-2 From an Infected Mother to Her Newborn. JAMA. 2020
• 305 Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W. et al. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. JAMA. 2020
• 306 Wang W, Xu Y, Gao R, Lu R, Han K, Wu G. et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020
• 307 Baud D, Greub G, Favre G, Gengler C, Jaton K, Dubruc E. et al. Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection. JAMA. 2020
• 308 Patane L, Morotti D, Giunta MR, Sigismondi C, Piccoli MG, Frigerio L. et al. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth. Am J Obstet Gynecol MFM. 2020:100145
• 309 Hecht JL, Quade B, Deshpande V, Mino-Kenudson M, Ting DT, Desai N. et al. SARS-CoV- 2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Mod Pathol. 2020
• 310 Cui D, Liu Y, Jiang X, Ding C, Poon LC, Wang H. et al. Single-cell RNA expression profiling of ACE2 and TMPRSS2 in the human trophectoderm and placenta. Ultrasound Obstet Gynecol. 2020
• 311 Bloise E, Zhang J, Nakpu J, Hamada H, Dunk CE, Li S. et al. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia. Am J Obstet Gynecol. 2020
• 312 Faure-Bardon V, Isnard P, Roux N, Leruez-Ville M, Molina T, Bessieres B. et al. Anatomical and timely assessment of protein expression of angiotensin-converting enzyme 2, SARS-CoV-2 specific receptor, in fetal and placental tissues: new insight for perinatal counseling. Ultrasound Obstet Gynecol. 2020
• 313 Weatherbee BAT, Glover DM, Zernicka-Goetz M. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester. Open Biol 2020; 10: 200162
• 314 Taglauer E, Benarroch Y, Rop K, Barnett E, Sabharwal V, Yarrington C. et al. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta. 2020; 100: 69-74
• 315 Pique-Regi R, Romero R, Tarca AL, Luca F, Xu Y, Alazizi A. et al. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? Elife. 2020;9
• 316 Komine-Aizawa S, Takada K, Hayakawa S. Placental barrier against COVID-19. Placenta. 2020; 99: 45-49
• 317 Kreis NN, Ritter A, Louwen F, Yuan J. A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2. Cells. 2020;9(8)
• 318 Hijona Elosegui JJ, Carballo Garcia AL, Fernandez Risquez AC, Bermudez Quintana M, Exposito Montes JF. Does the maternal-fetal transmission of SARS-CoV-2 occur during pregnancy? Rev Clin Esp. 2020
• 319 Auriti C, De Rose DU, Tzialla C, Caforio L, Ciccia M, Manzoni P. et al. Vertical Transmission of SARS-CoV-2 (COVID-19): Are Hypotheses More than Evidences?. Am J Perinatol 2020; 37: S31-S38
• 320 Schwartz A, Yogev Y, Zilberman A, Alpern S, Many A, Yousovich R. et al. Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vaginal swabs of women with acute SARS-CoV-2 infection: a prospective study. BJOG. 2021; 128: 97-100
• 321 Ansari K, Kew T, Allotey J, Thangaratinam S. Mother-to-child transmission of severe acute respiratory syndrome coronavirus 2: review of classification systems and systematic reviews. Curr Opin Obstet Gynecol 2021; 33: 391-399
• 322 Pulinx B, Kieffer D, Michiels I, Petermans S, Strybol D, Delvaux S. et al. Vertical transmission of SARS-CoV-2 infection and preterm birth. Eur J Clin Microbiol Infect Dis. 2020
• 323 Sisman J, Jaleel MA, Moreno W, Rajaram V, Collins RRJ, Savani RC. et al. Intrauterine Transmission of SARS-COV-2 Infection in a Preterm Infant. Pediatr Infect Dis J 2020; 39: e265-e267
• 324 Deniz M, Tezer H. Vertical transmission of SARS CoV-2: a systematic review. J Matern Fetal Neonatal Med. 2020:1-8
• 325 Walker KF, O'Donoghue K, Grace N, Dorling J, Comeau JL, Li W. et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG. 2020; 127: 1324-1336
• 326 Norman M, Naver L, Soderling J, Ahlberg M, Hervius Askling H, Aronsson B. et al. Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes. JAMA. 2021; 325: 2076-2086
• 327 Stanoeva KR, van der Eijk AA, Meijer A, Kortbeek LM, Koopmans MPG, Reusken C. Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies. Euro Surveill. 2021;26(10)
• 328 Hayakawa S, Komine-Aizawa S, Mor GG. Covid-19 pandemic and pregnancy. J Obstet Gynaecol Res. 2020
• 329 Dubelbeiss E, Silverberg M, White C, Jaspan D, Goldberg J, Haines C. Repeat positive severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) testing>/=90 days apart in pregnant women. Am J Obstet Gynecol MFM 2021; 3: 100331
• 330 Baptiste C, Breslin N, Chong A, Vallese F, Costabile BK, Fuchs K. et al. 919 Rates of seroprevalance of COVID-19 among pregnant patients in New York City. American Journal of Obstetrics and Gynecology. 2021; 224: S571-S.
• 331 Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W. et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020; 296: E32-E40
• 332 Alay I, Yildiz S, Kaya C, Yasar KK, Aydin OA, Karaosmanoglu HK. et al. The clinical findings and outcomes of symptomatic pregnant women diagnosed with or suspected of having coronavirus disease 2019 in a tertiary pandemic hospital in Istanbul, Turkey. J Obstet Gynaecol Res. 2020
• 333 Francis S, Mathew RP, Khalid ZA. Coronavirus (COVID-19) Infection in Pregnancy: Does Non-contrast Chest Computed Tomography (CT) Have a Role in Its Evaluation and Management?. J Obstet Gynaecol India 2020; 70: 272-274
• 334 Oshay RR, Chen MYC, Fields BKK, Demirjian NL, Lee RS, Mosallaei D. et al. COVID-19 in pregnancy: a systematic review of chest CT findings and associated clinical features in 427 patients. Clin Imaging 2021; 75: 75-82
• 335 Chong WH, Saha BK, Conuel E, Chopra A. The incidence of pleural effusion in COVID-19 pneumonia: State-of-the-art review. Heart Lung 2021; 50: 481-490
• 336 Yassa M, Yirmibes C, Cavusoglu G, Eksi H, Dogu C, Usta C et al. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study. J Matern Fetal Neonatal Med 2020; 33: 3820–3826
• 337 Yassa M, Yirmibes C, Cavusoglu G, Eksi H, Dogu C, Usta C. et al. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study. J Matern Fetal Neonatal Med 2020; 33: 3820-3826
• 338 Peixoto AO, Costa RM, Uzun R, Fraga AMA, Ribeiro JD, Marson FAL. Applicability of lung ultrasound in COVID-19 diagnosis and evaluation of the disease progression: A systematic review. Pulmonology. 2021
• 339 Deng Q, Cao S, Wang H, Zhang Y, Chen L, Yang Z. et al. Application of quantitative lung ultrasound instead of CT for monitoring COVID-19 pneumonia in pregnant women: a single- center retrospective study. BMC Pregnancy Childbirth 2021; 21: 259
• 340 Sperandeo M, Trovato GM. Care of future mothers amid the COVID-19 outbreak: is there a monitoring role for lung ultrasound?. Ultrasound Obstet Gynecol 2020; 56: 469-470
• 341 Quarato CMI, Venuti M, Lacedonia D, Simeone A, Sperandeo M. Diagnosis and monitoring of COVID-19 pneumonia in pregnant women: is lung ultrasound appropriate?. Ultrasound Obstet Gynecol 2020; 56: 467-468
• 342 Duffy CR, Hart JM, Modest AM, Hacker MR, Golen T, Li Y. et al. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients. Obstet Gynecol 2020; 136: 229-31.
• 343 Wei L, Gao X, Chen S, Zeng W, Wu J, Lin X. et al. Clinical Characteristics and Outcomes of Childbearing-Age Women With COVID-19 in Wuhan: Retrospective, Single-Center Study. J Med Internet Res 2020; 22: e19642
• 344 Vivanti AJ, Mattern J, Vauloup-Fellous C, Jani J, Rigonnot L, El Hachem L. et al. Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France. Emerg Infect Dis 2020; 26: 2069-2076
• 345 Copaescu A, James F, Mouhtouris E, Vogrin S, Smibert OC, Gordon CL. et al. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study. Front Immunol 2021; 12: 646095
• 346 Tanacan A, Yazihan N, Erol SA, Anuk AT, Yucel Yetiskin FD, Biriken D. et al. The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study. Cytokine. 2021; 140: 155431
• 347 Liu YM, Xie J, Chen MM, Zhang X, Cheng X, Li H. et al. Kidney Function Indicators Predict Adverse Outcomes of COVID-19. Med (N Y) 2021; 2: 38-48 e2
• 348 Zhou J, Wang Y, Zhao J, Gu L, Yang C, Wang J. et al. The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonates. Eur J Clin Microbiol Infect Dis 2021; 40: 565-574
• 349 Kubiak JM, Murphy EA, Yee J, Cagino KA, Friedlander RL, Glynn SM. et al. Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates. Am J Obstet Gynecol 2021; 225: 73 e1-e7
• 350 Federici L, Picone O, Dreyfuss D, Sibiude J. Successful continuation of pregnancy in a patient with COVID-19-related ARDS. BMJ Case Rep. 2020;13(8)
• 351 Futterman I, Toaff M, Navi L, Clare CA. COVID-19 and HELLP: Overlapping Clinical Pictures in Two Gravid Patients. AJP Rep 2020; 10: e179-e182
• 352 Zitiello A, Grant GE, Ben Ali N, Feki A. Thrombocytopaenia in pregnancy: the importance of differential diagnosis during the COVID-19 pandemic. J Matern Fetal Neonatal Med. 2020:1-3
• 353 Ahmed I, Eltaweel N, Antoun L, Rehal A. Severe pre-eclampsia complicated by acute fatty liver disease of pregnancy, HELLP syndrome and acute kidney injury following SARS-CoV- 2 infection. BMJ Case Rep. 2020;13(8)
• 354 Avila WS, Carvalho RC. COVID-19: A New Challenge in Pregnancy and Heart Disease. Arq Bras Cardiol 2020; 115: 1-4
• 355 Dap M, Morel O. Proteinuria in Covid-19 pregnant women: Preeclampsia or severe infection?. Eur J Obstet Gynecol Reprod Biol 2020; 252: 612
• 356 López Pérez V, Cora Vicente J, Echeverría Granados C, Salcedo Vázquez ML, Estol F, Tebar Cuesta MY. Postpartum consciousness disturbance: Can COVID-19 cause posterior reversible encephalopathy syndrome?. Revista Española de Anestesiología y Reanimación (English Edition) 2020; 67: 511-515
• 357 Gewirtz AN, Gao V, Parauda SC, Robbins MS. Posterior Reversible Encephalopathy Syndrome. Curr Pain Headache Rep 2021; 25: 19
• 358 AWMF. S3-Leitlinie - Empfehlungen zur stationären Therapie von Patienten mit COVID- 19 2021 [updated 05.10.2021. Available from https://www.awmf.org/uploads/tx_szleitlinien/113-001LGl_S3_Empfehlungen-zur- stationaeren-Therapie-von-Patienten-mit-COVID-19_2021-10_1.pdf.
• 359 RECOVERY Collaborative Group PWH Mafham M, Peto Leon, Campbell Mark, Pessoa-Amorim Guilherme, Spata Enti, Staplin N, Emberson JR, Prudon B, Hine P, Brown T, Green CA, Sarkar R, Desai P, Yates B, Bewick T, Tiberi S, Felton T, Baillie JK, Buch MH, Chappell LC, Day JN, Faust SN, Jaki T, Jeffery K, Juszczak E, Lim WS, Montgomery A, Mumford A, Rowan K, Thwaites G, Weinreich DM, Haynes R, Landray MJ. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. medRxiv 2021061521258542. 2021
• 360 Chambers CD, Johnson DL, Xu R, Luo Y, Lopez-Jimenez J, Adam MP. et al. Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study. PLoS One 2019; 14: e0223603
• 361 Puchner A, Grochenig HP, Sautner J, Helmy-Bader Y, Juch H, Reinisch S. et al. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation. Wien Klin Wochenschr 2019; 131: 29-44
• 362 Mayer C, VanHise K, Caskey R, Naqvi M, Burwick RM. Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2021 ..
• 363 Wieringa JW, van der Woude CJ. Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2020; 44-45: 101665
• 364 Agrawal M, Kim ES, Colombel JF. JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications. J Crohns Colitis 2020; 14: S755-S760
• 365 Mahadevan U, Dubinsky MC, Su C, Lawendy N, Jones TV, Marren A. et al. Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. Inflamm Bowel Dis 2018; 24: 2494-2500
• 366 Clowse ME, Feldman SR, Isaacs JD, Kimball AB, Strand V, Warren RB. et al. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis. Drug Saf 2016; 39: 755-762
• 367 Costanzo G, Firinu D, Losa F, Deidda M, Barca MP, Del Giacco S. Baricitinib exposure during pregnancy in rheumatoid arthritis. Ther Adv Musculoskelet Dis 2020; 12: 1759720X19899296
• 368 Berard A, Sheehy O, Zhao JP, Vinet E, Quach C, Kassai B. et al. Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy. PLoS One 2021; 16: e0251746
• 369 RCOG. Coronavirus (COVID-19) Infection in Pregnancy 2021 [updated 25.08.2021. Available from https://www.rcog.org.uk/globalassets/documents/guidelines/2021-08-25- coronavirus-covid-19-infection-in-pregnancy-v14.pdf
• 370 Medicine SfM-F. Management Considerations for Pregnant Patients With COVID-19 2021 [updated 01.07.2021. Available from https://s3.amazonaws.com/cdn.smfm.org/media/2734/SMFM_COVID_Management_of_COVI D_pos_preg_patients_2-2-21_(final).pdf
• 371 Hoeltzenbein M, Beck E, Rajwanshi R, Gotestam Skorpen C, Berber E, Schaefer C. et al. Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data. Semin Arthritis Rheum 2016; 46: 238-245
• 372 Nakajima K, Watanabe O, Mochizuki M, Nakasone A, Ishizuka N, Murashima A. Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan. Mod Rheumatol 2016; 26: 667-671
• 373 Saito J, Yakuwa N, Kaneko K, Takai C, Goto M, Nakajima K. et al. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum. Rheumatology (Oxford) 2019; 58: 1505-1507
• 374 Abdullah S, Bashir N, Mahmood N. Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports. J Med Case Rep 2021; 15: 426
• 375 Group RC, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL. et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med 2021; 384: 693-704
• 376 Jimenez-Lozano I, Caro-Teller JM, Fernandez-Hidalgo N, Miarons M, Frick MA, Batllori Badia E. et al. Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study. J Clin Pharm Ther 2021; 46: 1062-1070
• 377 Louchet M, Sibiude J, Peytavin G, Picone O, Treluyer JM, Mandelbrot L. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019. Am J Obstet Gynecol MFM 2020; 2: 100159
• 378 Tada Y, Sakai M, Nakao Y, Maruyama A, Ono N, Koarada S. Placental transfer of tocilizumab in a patient with rheumatoid arthritis. Rheumatology (Oxford) 2019; 58: 1694-1695
• 379 Saito J, Yakuwa N, Takai C, Nakajima K, Kaneko K, Goto M. et al. Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study. Rheumatology (Oxford) 2018; 57: 1499-1501
• 380 Gotestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C. et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 2016; 75: 795-810
• 381 Zhang S, Li L, Shen A, Chen Y, Qi Z. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia. Clin Drug Investig 2020; 40: 511-518
• 382 Jorgensen SCJ, Lapinsky SE. Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review. Clin Microbiol Infect. 2021
• 383 Gavillet M, Rolnik DL, Hoffman MK, Panchaud A, Baud D. Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?. Ultrasound Obstet Gynecol 2020; 55: 843-844
• 384 Pourdowlat G, Mikaeilvand A, Eftekhariyazdi M, Nematshahi M, Ebrahimi M, Kazemzadeh A. Prone-Position Ventilation in a Pregnant Woman with Severe COVID-19 Infection Associated with Acute Respiratory Distress Syndrome. Tanaffos. 2020; 19: 152-155
• 385 Donzelli M, Ippolito M, Catalisano G, Renda B, Tarantino F, Diquattro O. et al. Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID-19. Clin Case Rep 2020; 8: 3352-3358
• 386 de Prost N, Bastard P, Arrestier R, Fourati S, Mahevas M, Burrel S. et al. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life- Threatening COVID-19 Pneumonia. J Clin Immunol 2021; 41: 536-544
• 387 Tambawala ZY, Hakim ZT, Hamza LK, Al Rayes M. Successful management of severe acute respiratory distress syndrome due to COVID-19 with extracorporeal membrane oxygenation during mid-trimester of pregnancy. BMJ Case Rep. 2021;14(2)
• 388 Shaefi S, Brenner SK, Gupta S, O'Gara BP, Krajewski ML, Charytan DM. et al. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID- 19. Intensive Care Med 2021; 47: 208-221
• 389 Barrantes JH, Ortoleva J, O'Neil ER, Suarez EE, Beth Larson S, Rali AS. et al. Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation. ASAIO J 2021; 67: 132-136
• 390 Takayama W, Endo A, Yoshii J, Arai H, Oi K, Nagaoka E. et al. Severe COVID-19 Pneumonia in a 30-Year-Old Woman in the 36th Week of Pregnancy Treated with Postpartum Extracorporeal Membrane Oxygenation. Am J Case Rep 2020; 21: e927521
• 391 Perricone C, Triggianese P, Bursi R, Cafaro G, Bartoloni E, Chimenti MS. et al. Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections. Microorganisms. 2021;9(1)
• 392 Sahu KK, Mishra AK, Raturi M, Lal A. Current Perspectives of convalescent plasma therapy in COVID-19. Acta Biomed 2020; 91: e2020175
• 393 Samad N, Sodunke TE, Banna HA, Sapkota A, Fatema AN, Iskandar K. et al. Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic. Risk Manag Healthc Policy 2020; 13: 2707-2728
• 394 Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta 2020; 506: 145-148
• 395 Group EC-W. COVID-19 vaccination and assisted reproduction - Statement from the ESHRE COVID-19 Working Group 2021 [Date of publication: 12 January 2021 Last update: 12 January ]. Available from https://www.eshre.eu/Press-Room/ESHRE-News
• 396 WHO SAGoEoIS. Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 2021 [updated 25.01.2021. Available from https://www.who.int/publications/i/item/interim-recommendations-for-use-of-the-moderna- mrna-1273-vaccine-against-covid-19
• 397 Crane MA, Jaffe E, Beigi RH, Karron RA, Krubiner CB, Wonodi CB. et al. Prioritization of pregnant individuals in state plans for coronavirus disease 2019 vaccination. Am J Obstet Gynecol. 2021
• 398 CDC Centers for Disease Control and Prevention. Information about COVID-19 Vaccines for People who Are Pregnant or Breastfeeding 2021 [Available from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
• 399 jpost. Health ministry updates priority list for COVID-19 vaccines. 2020 2021 [Available from https://www.jpost.com/breaking-news/health-ministryupdates- priority-list-for-covid-19-vaccines-652738
• 400 Government U. JCVI issues new advice on COVID-19 vaccination for pregnant women 2021 [Press release]. Available from https://www.gov.uk/government/news/jcvi-issues-new- advice-on-covid-19-vaccination-for-pregnant-women.
• 401 Razzaghi H, Meghani M, Pingali C, Crane B, Naleway A, Weintraub E. et al. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep 2021; 70: 895-899
• 402 EU. SUMMARY OF PRODUCT CHARACTERISTICS [Available from https://ec.europa.eu/health/documents/community- register/2020/20201221150522/anx_150522_en.pdf
• 403 FDA. FDA Briefing Document Moderna COVID-19 Vaccine 2020 [Available from: https://www.fda.gov/media/144434/download
• 404 CDC. V-safe Pregnancy Regostry: Center for Disease Control and Prevention; 2021 [updated 27.04.2021. Available from: https://www.cdc.gov/coronavirus/2019- ncov/vaccines/safety/vsafepregnancyregistry.html
• 405 Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L. et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021
• 406 Zauche LH, Wallace B, Smoots AN, Olson CK, Oduyebo T, Kim SY. et al. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. N Engl J Med. 2021
• 407 Wainstock T, Yoles I, Sergienko R, Sheiner E. Prenatal maternal COVID-19 vaccination and pregnancy outcomes. Vaccine. 2021
• 408 Kharbanda EO, Haapala J, DeSilva M, Vazquez-Benitez G, Vesco KK, Naleway AL. et al. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. JAMA. 2021
• 409 Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K. et al. COVID-19 Vaccination During Pregnancy: Coverage and Safety. Am J Obstet Gynecol. 2021
• 410 Bookstein Peretz S, Regev N, Novick L, Nachshol M, Goffer E, Ben-David A. et al. Short- term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine. Ultrasound Obstet Gynecol 2021; 58: 450-456
• 411 European Network of Teratology Information Services (ENTIS). Position statement on COVID-19 vaccines during pregnancy & lactation 2021 [Available from https://www.entis-org.eu/wp-content/uploads/2021/04/ENTIS-Position-Paper-on- COVID_Vaccine_in_pregnancy.pdf
• 412 Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N. et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021
• 413 Kachikis A, Englund JA, Singleton M, Covelli I, Drake AL, Eckert LO. Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout. JAMA Network Open 2021; 4: e2121310-e2121310
• 414 COVID-10 vaccine safety monitoring in US: no serious concerns. Reactions Weekly 2021; 1844: 8 -
• 415 Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L. et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med 2021; 384: 2273-2282
• 416 Atyeo C, DeRiso EA, Davis C, Bordt EA, DeGuzman RM, Shook LL. et al. COVID-19 mRNA vaccines drive differential Fc-functional profiles in pregnant, lactating, and non-pregnant women. bioRxiv. 2021
• 417 Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N. et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. medRxiv. 2021
• 418 Beharier O, Plitman Mayo R, Raz T, Nahum Sacks K, Schreiber L, Suissa-Cohen Y. et al. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J Clin Invest. 2021;131(13)
• 419 Prabhu M, Murphy EA, Sukhu AC, Yee J, Singh S, Eng D. et al. Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood. Obstet Gynecol 2021; 138: 278-280
• 420 Collier AY, McMahan K, Yu J, Tostanoski LH, Aguayo R, Ansel J. et al. Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. JAMA. 2021; 325: 2370-2380
• 421 Butt AA-SA-B, Chemaitelly H, Khal AA, Coyle P, Saleh H. et al. Effectiveness of the SARS-CoV-2 mRNA Vaccines in Pregnant Women. Research Square 2021
• 422 Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS. et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 2021
• 423 Regan NTMW, Amy W, Ramila M, Abinash V, Melanie S. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. medrxiv2021. 2021
• 424 Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G. et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA. 2021; 326: 728-735
• 425 Mithal LB, Otero S, Shanes ED, Goldstein JA, Miller ES. Cord Blood Antibodies following Maternal COVID-19 Vaccination During Pregnancy. Am J Obstet Gynecol. 2021
• 426 Rottenstreich A, Zarbiv G, Oiknine-Djian E, Zigron R, Wolf DG, Porat S. Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination. Clin Infect Dis. 2021
• 427 Mithal LB, Otero S, Shanes ED, Goldstein JA, Miller ES. Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy. Am J Obstet Gynecol 2021; 225: 192-194
• 428 Atyeo C, Pullen KM, Bordt EA, Fischinger S, Burke J, Michell A. et al. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021; 184: 628-642 e10
• 429 Vono M, Eberhardt CS, Auderset F, Mastelic-Gavillet B, Lemeille S, Christensen D. et al. Maternal Antibodies Inhibit Neonatal and Infant Responses to Vaccination by Shaping the Early-Life B Cell Repertoire within Germinal Centers. Cell Reports 2019; 28: 1773-1784 e5
• 430 Kelly JC, Carter EB, Raghuraman N, Nolan LS, Gong Q, Lewis AN. et al. Anti-severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer- BioNTech/BNT162b2 vaccination. Am J Obstet Gynecol. 2021
• 431 Esteve-Palau E, Gonzalez-Cuevas A, Guerrero ME, Garcia-Terol C, Alvarez MC, Casadevall D. et al. Quantification of Specific Antibodies Against SARS-CoV-2 in Breast Milk of Lactating Women Vaccinated With an mRNA Vaccine. JAMA Netw Open 2021; 4: e2120575
• 432 Juncker HG, Mulleners SJ, van Gils MJ, de Groot CJM, Pajkrt D, Korosi A. et al. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination. J Hum Lact 2021; 37: 477-484
• 433 Baird JK, Jensen SM, Urba WJ, Fox BA, Baird JR. SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination. J Hum Lact 2021; 37: 492-498
• 434 Schwartz A, Nir O, Toussia-Cohen S, Leibovich L, Strauss T, Asraf K. et al. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine. Am J Obstet Gynecol. 2021
• 435 Golan Y, Prahl M, Cassidy A, Lin CY, Ahituv N, Flaherman VJ. et al. COVID-19 mRNA vaccine is not detected in human milk. medRxiv. 2021:2021.03.05.21252998
• 436 Low JM, Gu Y, Ng MSF, Amin Z, Lee LY, Ng YPM. et al. Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees. NPJ Vaccines 2021; 6: 105
• 437 Carbone L, Mappa I, Sirico A, Di Girolamo R, Saccone G, Di Mascio D. et al. Pregnant women's perspectives on severe acute respiratory syndrome coronavirus 2 vaccine. Am J Obstet Gynecol MFM 2021; 3: 100352
• 438 Tkaczyszyn K, Kuchar E, Augustynowicz E, Szenborn L. The Impact of a Single Educational Lecture on the Vaccine Confidence among Pregnant Women and Young Mothers. Vaccines (Basel). 2021;9(3)
• 439 Blasi F, Gramegna A, Sotgiu G, Saderi L, Voza A, Aliberti S. et al. SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity. Respir Med 2021; 180: 106355